#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3992	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2393	376.9	0	.	n	.	0	C451T	SNP	451	451	C	639	639	T	437	T,C,A,G	299,114,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3992	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2393	376.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1372	1372	C	410	C,A,G	379,3,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3992	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2393	376.9	0	HET	.	.	.	C207T	.	207	207	C	395	395	C	366	C,T	228,108	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7214	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4579	386.0	0	.	n	.	0	T695C	SNP	695	695	T	1454	1454	C	371	C,A,G	350,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7214	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4579	386.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2730	2730	C	557	C,G,A	522,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7214	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4579	386.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2804	2804	A	569	A,C,T	535,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7214	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4579	386.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3356	3356	C	514	C,T,A	504,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7214	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4579	386.0	0	HET	.	.	.	A1638G,C	.	1638	1638	A	2397	2397	A	514	A,G,C	382,121,2	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	968	folP	855	855	100.0	folP.l15.c4.ctg.1	2005	114.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1339	1341	AGC	149;147;144	A,G,C;G;C,G	143,2,2;146;141,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	117.9	1	SNP	p	S91F	1	.	.	271	273	TTC	913	915	TTC	112;113;113	T;T;C	102;99;103	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	117.9	1	SNP	p	D95G	1	.	.	283	285	GGC	925	927	GGC	124;125;125	G;G,T;C	117;117,1;118	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	117.9	1	SNP	p	G95N	0	.	.	283	285	GGC	925	927	GGC	124;125;125	G;G,T;C	117;117,1;118	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	686	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	2000	84.4	1	SNP	p	G45D	0	.	.	133	135	GGC	825	827	GGC	161;164;164	G;G;C	142;145;148	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	560	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1749	78.3	0	.	n	.	0	A197.	DEL	197	197	A	981	981	A	188	A	183	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	1	SNP	p	D86N	0	.	.	256	258	GAC	1006	1008	GAC	123;123;127	G;A,T,G;C	98;78,1,1;99	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	1	SNP	p	R87I	0	.	.	259	261	CGT	1009	1011	CGT	127;127;130	C;G;T,G	110;91;100,2	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	1	SNP	p	S87R	1	.	.	259	261	CGT	1009	1011	CGT	127;127;130	C;G;T,G	110;91;100,2	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	1	SNP	p	R87W	0	.	.	259	261	CGT	1009	1011	CGT	127;127;130	C;G;T,G	110;91;100,2	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	1	SNP	p	S88P	0	.	.	262	264	TCC	1012	1014	TCC	130;130;130	T,G;C,T,G;C	111,1;113,2,1;121	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	2280	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3654	153.2	0	HET	.	.	.	T1526G,A	.	1526	1526	T	2276	2276	T	151	T,G,A	120,20,5	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1866	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3501	129.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2014	2016	GGC	137;139;140	G;G;C,G	124;120;106,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1685	1687	GCC	142;144;144	G;C;C,A	139;142;141,1	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1688	1690	ATG	143;145;145	A;T,G;G	141;142,1;142	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1700	1702	ACC	152;153;152	A,G,T;C,T,A;C	147,1,1;148,1,1;149	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1700	1702	ACC	152;153;152	A,G,T;C,T,A;C	147,1,1;148,1,1;149	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2201	2203	ACC	114;114;112	A;C,A;C	104;99,4;109	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2255	2257	GCG	98;99;99	G;C,G;G	86;75,1;87	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2255	2257	GCG	98;99;99	G;C,G;G	86;75,1;87	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2378	2380	GGT	88;88;87	G;GTT,GT;T,A,C	84;46,1;81,1,1	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2387	2389	AGC	83;83;82	A;G;C,G,A	46;62;47,5,2	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1232	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2891	101.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2405	2407	CCG	81;81;80	C,G;C,T,G;G,A,T,C	64,1;55,1,1;64,1,1,1	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1796	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3831	113.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1971	1973	CCG	160;161;160	C,G,T;C;G,C,T	111,8,5;143;100,12,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	856	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2316	89.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	834	834	C	58	C,G	48,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	846	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2512	82.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1404	1406	AGA	133;141;143	A;G;A	128;135;137	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	846	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2512	82.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1425	1427	GGT	113;113;113	G;G;T	108;108;104	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	846	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2512	82.7	1	SNP	p	G120K	1	.	.	358	360	AAG	1134	1136	AAG	120;119;121	A,C;A;G,A	116,3;118;119,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	846	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2512	82.7	1	SNP	p	A121N	1	.	.	361	363	AAC	1137	1139	AAC	124;124;124	A;A;C	122;121;119	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	846	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2512	82.7	1	SNP	p	N121D	0	.	.	361	363	AAC	1137	1139	AAC	124;124;124	A;A;C	122;121;119	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2434	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5423	110.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	302	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1763	42.4	1	SNP	p	V57M	1	.	.	169	171	ATG	925	927	ATG	81;82;82	A;T;G	75;78;78	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
